CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

91 hedge funds and large institutions have $152M invested in Cascadian Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$50K
Puts
$1K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$33.5M
2
$32.3M
3
$11.6M
4
$10.1M
5
$9.2M
6
$7.87M
7
$7.03M
8
$3.43M
9
$3.42M
10
$3.24M
11
$2.74M
12
$2.52M
13
$2.46M
14
$2.4M
15
$1.89M
16
$1.83M
17
$1.45M
18
$1.44M
19
$1.41M
20
$965K
21
$889K
22
$740K
23
$683K
24
$567K
25
$542K